Despite the fact that the oxindole has long been thought to be the best structural scaffold, research shows that oxindole derivatives are being studied the least against tuberculosis (TB), a historically airborne illness.The present research focuses on the development of 3-substituted-2-oxindole derivatives with a combination of structural and functional alterations in order to create dual-active new chem. entities with anti-TB, anti-oxidant, and radical-scavenging properties.The physicochem. properties of these compounds are in line with the theories of Lipinski, Veeber, and Leeson.SWISSADME was used to assess the drug-like mol. nature and pharmacokinetics features.Multistep synthetic procedures were used to synthesize the chems.Based on in vitro anti-TB and radical scavenging property analyses, the synthesized 3-substituted-2-oxindole derivatives were confirmed as dual-active compoundsThe synthesized 3-substituted-2-oxindole derivatives were confirmed to possess the dual therapeutics action.The discovery of radical scavengers 4d, 4a, 4c, 3d, 3c, 3f, 3e, 3h, 3g, and 3j that are more potent than Ascorbic acid, the standardThe mols., 3c, 3j, 3b, and 4b have exhibited moderate to active anti-TB properties with a % reduction values of 46.42%, 40.89%, 39.76% and 39.32%, resp.The findings suggest that fine-tuning mols. might result in compounds with better anti-TB and radical-scavenging properties.